InflaRx Announces Pricing of $40 Million Public Offering of Ordinary Shares

April 11, 2023

https://www.globenewswire.com/news-release/2023/04/12/2645013/0/en/InflaRx-Announces-Pricing-of-40-Million-Public-Offering-of-Ordinary-Shares.html

JENA, Germany, April 12, 2023 (GLOBE NEWSWIRE) — InflaRx N.V. (Nasdaq:IFRX) (the “Company”), a clinical-stage biopharmaceutical company developing anti-inflammatory therapeutics by targeting the complement system, announced today the pricing of its underwritten public offering of 9,411,765 ordinary shares at an offering price of $4.25 per ordinary share. The offering is expected to close on April 14, 2023, subject to the satisfaction of customary closing conditions.

Read more at globenewswire.com

Related news for (IFRX)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.